ArticleFrontiers in computational neuroscience2024
Automated karyogram analysis for early detection of genetic and neurodegenerative disorders: a hybrid machine learning approach.
Article in Frontiers in computational neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Automated karyotyping and structural anomaly detection through a hybrid multi-stage deep learning framework integrating chromosome detection, pairwise classification, and autoencoder-based analysis.Scientific reports · 2026Article
- Artificial intelligence in haematology laboratory diagnosis: Current applications, challenges, and future directions.African journal of laboratory medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anomalous chromosomes are the cause of genetic diseases such as cancer, Alzheimer's, Parkinson's, epilepsy, and autism. Karyotype analysis is the standard procedure for diagnosing genetic disorders. Identifying anomalies is often costly, time-consuming, heavily reliant on expert interpretation, and requires considerable manual effort. Efforts are being made to automate karyogram analysis. However, the unavailability of large datasets, particularly those including samples with chromosomal abnormalities, presents a significant challenge. The development of automated models requires extensive labeled and incredibly abnormal data to accurately identify and analyze abnormalities, which are difficult to obtain in sufficient quantities. Although the deep learning-based architecture has yielded state-of-the-art performance in medical image anomaly detection, it cannot be generalized well because of the lack of anomalous datasets. This study introduces a novel hybrid approach that combines unsupervised and supervised learning techniques to overcome the challenges of limited labeled data and scalability in chromosomal analysis. An Autoencoder-based system is initially trained with unlabeled data to identify chromosome patterns. It is fine-tuned on labeled data, followed by a classification step using a Convolutional Neural Network (CNN). A unique dataset of 234,259 chromosome images, including the training, validation, and test sets, was used. Marking a significant achievement in the scale of chromosomal analysis. The proposed hybrid system accurately detects structural anomalies in individual chromosome images, achieving 99.3% accuracy in classifying normal and abnormal chromosomes. We also used a structural similarity index measure and template matching to identify the part of the abnormal chromosome that differed from the normal one. This automated model has the potential to significantly contribute to the early detection and diagnosis of chromosome-related disorders that affect both genetic health and neurological behavior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.